PortIO


MARKET OPPORTUNITY

 

CLINICAL

  • Implantable vascular access devices for delivery of medications and other substances over weeks to months

 

ADDRESSABLE MARKET

  • Total: All implantable ports1 ~$500M
  • Immediate: Poor venous access patients ~$50M

 

CURRENT DEVICE LIMITATIONS

  • Intravascular component prone to clotting and infection
  • Occlusions requiring intervention (30%2)
  • Labor-intensive maintenance regimens (regular flushes)
  • Surgical insertion/removal
  • Requires radiographic confirmation
  • Many patients with poor venous access
  

PAVMED SOLUTION

 

PORTIO

  • A novel, implantable intraosseous vascular access device
  • No intravascular component

 

LESS INVASIVE

  • Near percutaneous insertion/removal

 

MORE COST EFFECTIVE

  • Not prone to occlusions so does not need regular flushes
  • No radiographic confirmation
  • Shift procedures from OR to interventional suite or office

 

FEWER COMPLICATIONS

  • Fewer occlusions and associated disruption of therapy
  • Potential for fewer, less serious infectious complications

 

MORE VERSATILE

  • Near limitless number of potential access sites including patients with occluded central veins



This product is in the development phase and has yet to receive regulatory approval.